Accretive M&A Activity - Connecticut
($ in thousands)
(All amounts expressed in thousands of U.S. Dollars)
Verano Holdings Corporation Pro Forma
Unaudited Reconciliation of Net Income to Adjusted EBITDA and Non-IFRS
For the Three Months Ended September 30, 2021 and 2020
For the Three Months Ended
9/30/21
(Unaudited)
6/30/21
(Unaudited)
9/30/20
(Unaudited)
Net Income¹
Depreciation and Amortization
$
103,715
6,830
$
81,612
9,851
9,404
3,498
Interest Expense, Net
8,068
5,531
2,868
Income Tax Expense
73,733
5,088
17,879
Earnings (Loss) Before Interest, Taxes, Depreciation
and Amortization (EBITDA) (Non-IFRS)
$
195,367
$
26,853
105,858
Other expense (income), net
RTO, M&A, and Transaction Costs
Inventory Step Up
Employee Earnout Accrual
Other non-operating costs
Adjusted EBITDA (Non-IFRS)
445
88
(3,161)
1,062
6,923
48
277
5,718.3
(2,642)
10,348
4,992
6,623
128
$
$
199,501
56,553
$
102,873
Net Impact of Fair Value of Biological Assets
(88,804)
24,921
(47,226)
Adjusted EBITDA (non-IFRS), Net of Impact of Biological Assets
$
110,697
$
81,474
$
55,648
VERANO.COM
veranoView entire presentation